Advertisement
Screener

ASTROTECH Corp (ASTC) Net Cash Provided by (Used in) Investing Activities, Continuing Operations

2.0 / 5 stars · 32/79 Roast Me

ASTROTECH Corp Net Cash Provided by (Used in) Investing Activities, Continuing Operations

ASTROTECH Corp (ASTC) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $7.88 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-18.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-18

  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $87.00K, a 88.16% decline year-over-year.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $735.00K, a 27.30% decline year-over-year.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $1.90M, a 156.33% increase year-over-year.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was $3.31M.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $7.88M, a 16.45% decline from fiscal 2016.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $9.43M.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$33.95M.
  • ASTROTECH Corp net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$150.00K.
Period endNet Cash Provided by (Used in) Investing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filedNet Cash Provided by (Used in) Investing Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed
2017-06-30$87.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18
$7.88M
10-K · filed 2017-09-18
2017-03-31$7.79M
10-Q · filed 2017-05-09
2016-06-30$735.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18
$2.64M
derived: sum of 2 quarters · filed 2017-09-18
$5.95M
derived: sum of 3 quarters · filed 2017-09-18
$9.43M
10-K · filed 2017-09-18
2016-03-31$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09
$5.22M
derived: sum of 2 quarters · filed 2017-05-09
$8.70M
10-Q · filed 2017-05-09
$9.71M
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$3.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-10
$6.80M
10-Q · filed 2016-02-10
$7.81M
derived: sum of 3 quarters · filed 2016-09-29
$8.55M
derived: sum of 4 quarters · filed 2016-09-29
2015-09-30$3.48M
10-Q · filed 2015-11-12
$4.49M
derived: sum of 2 quarters · filed 2016-09-29
$5.23M
derived: sum of 3 quarters · filed 2016-09-29
-$30.42M
derived: sum of 4 quarters · filed 2016-09-29
2015-06-30$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-29
$1.75M
derived: sum of 2 quarters · filed 2016-09-29
-$33.90M
derived: sum of 3 quarters · filed 2016-09-29
-$33.95M
10-K · filed 2016-09-29
2015-03-31$742.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11
-$34.91M
derived: sum of 2 quarters · filed 2016-05-11
-$34.96M
10-Q · filed 2016-05-11
-$34.96M
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31-$35.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-10
-$35.70M
10-Q · filed 2016-02-10
-$35.70M
derived: sum of 3 quarters · filed 2016-02-10
-$35.75M
derived: sum of 4 quarters · filed 2016-02-10
2014-09-30-$46.00K
10-Q · filed 2015-11-12
-$47.00K
derived: sum of 2 quarters · filed 2015-11-12
-$102.00K
derived: sum of 3 quarters · filed 2015-11-12
-$155.00K
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-22
-$56.00K
derived: sum of 2 quarters · filed 2015-09-22
-$109.00K
derived: sum of 3 quarters · filed 2015-09-22
-$150.00K
10-K · filed 2015-09-22
-$368.00K
10-K · filed 2014-09-30
2014-03-31-$55.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11
-$108.00K
derived: sum of 2 quarters · filed 2015-05-11
-$149.00K
10-Q · filed 2015-05-11
-$305.00K
10-Q · filed 2014-05-14
-$1.06M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31-$53.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17
-$94.00K
10-Q · filed 2015-02-17
-$1.00M
derived: sum of 3 quarters · filed 2015-02-17
2013-09-30-$41.00K
10-Q · filed 2014-11-14
-$952.00K
derived: sum of 2 quarters · filed 2014-11-14
2013-06-30-$911.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30
-$1.85M
10-K · filed 2014-09-30
2013-03-31-$936.00K
10-Q · filed 2014-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15